Zhigang Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Zhigang Huang has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
Wei Guo
Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, PR China
10 shared publicationsGaofei Yin
Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China
9 shared publications- Gaofei Yin
Beijing Tongren Hospital, Capital Medical University, Beijing, China
6 shared publications Yang Zhang
Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China
5 shared publicationsJinlin Du
Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, People’s Republic of China
4 shared publications- Wei Guo
Beijing Tongren Hospital, Capital Medical University
4 shared publications
Latest Publications
- Open Access
- 10 August 2025
- Published by Life Conflux Press Limited in Head and Neck Diseases Conflux
- Vol. 1 (1) , e254
INAUGURAL EDITORIAL OF HEAD AND NECK DISEASES CONFLUX
Head and Neck Diseases Conflux is a pioneering international journal dedicated to catalyzing interdisciplinary research and clinical innovation in head and neck medicine. Central to our mission is the integration of diverse medical specialties and fostering global academic collaboration as cornerstones of scientific advancement. The intricate anatomy of the head and neck region, encompassing complex sensory, neurological, and vascular systems, necessitates seamless collaboration among ophthalmologists, otolaryngologists, neurosurgeons, and allied specialists. The journal champions the full spectrum of translational research, bridging fundamental molecular discoveries with cutting-edge clinical applications including minimally invasive endoscopic techniques, artificial intelligence-enhanced diagnostics, novel cold plasma therapeutics, robotic-assisted surgical precision, and personalized 3D-printed implants. Through our commitment to cultivating future medical leaders and upholding the highest standards of academic rigor, we aim to accelerate transformative technologies in precision medicine, tissue engineering, regenerative therapeutics, and gene-editing applications. By promoting global partnerships and scientific discourse, Head and Neck Diseases Conflux aspires to make substantial contributions to advancing healthcare through evidence-based innovation and clinical excellence.
- 10 August 2025
- Published by Life Conflux Press Limited in Head and Neck Diseases Conflux
- Vol. 1 (1) , e254
Open AccessINAUGURAL EDITORIAL OF HEAD AND NECK DISEASES CONFLUX
Head and Neck Diseases Conflux is a pioneering international journal dedicated to catalyzing interdisciplinary research and clinical innovation in head and neck medicine. Central to our mission is the integration of diverse medical specialties and fostering global academic collaboration as cornerstones of scientific advancement. The intricate anatomy of the head and neck region, encompassing complex sensory, neurological, and vascular systems, necessitates seamless collaboration among ophthalmologists, otolaryngologists, neurosurgeons, and allied specialists. The journal champions the full spectrum of translational research, bridging fundamental molecular discoveries with cutting-edge clinical applications including minimally invasive endoscopic techniques, artificial intelligence-enhanced diagnostics, novel cold plasma therapeutics, robotic-assisted surgical precision, and personalized 3D-printed implants. Through our commitment to cultivating future medical leaders and upholding the highest standards of academic rigor, we aim to accelerate transformative technologies in precision medicine, tissue engineering, regenerative therapeutics, and gene-editing applications. By promoting global partnerships and scientific discourse, Head and Neck Diseases Conflux aspires to make substantial contributions to advancing healthcare through evidence-based innovation and clinical excellence.
- 10 June 2025
- Published by SAGE Publications in Journal of Telemedicine and Telecare
- Vol. 32 (2) , 151-162
Exploration of a remote swallowing training model after laryngeal cancer surgery: Non-randomized concurrent controlled trial
Background: Patients with supraglottic laryngeal carcinoma need to receive swallowing rehabilitation training. During the COVID-19 pandemic, patients do not have the conditions to visit the hospital for follow up frequently, so it is imperative to explore a new remote rehabilitation training model based on network conditions. Objective: To explore the effect of remote rehabilitation training mode on improving postoperative swallowing function in patients with supraglottic laryngeal carcinoma. Methods: Patients undergoing remote rehabilitation and video rehabilitation after surgical treatment for supraglottic laryngeal cancer, 16 each, were collected, and swallowing function at the start of transoral feeding was assessed as a baseline to compare swallowing function and the occurrence of complications at different stages of training. Results: Patients in the remote group began to show significant improvement in subjective swallowing function from the second week ( P < .001). In terms of objective swallowing function, although the remote group did not show a significant ( P = .66) advantage initially, it was also significantly better than the control group in the fourth week ( P <.001). These effects are even more impressive in patients undergoing open surgery ( P <.001). When completed the rehabilitation phase, patients in the remote group had a better nutritional status ( P = .03), especially postlaser surgery patients ( P = .02). Conclusions: The remote rehabilitation training model has an improving effect on patients with supraglottic laryngeal cancer postoperative swallowing disorder, which provides a theoretical basis for the design and improvement of the future remote rehabilitation training model. This study suggests that this training model should be incorporated into the daily postoperative management of patients with laryngeal cancer to improve the efficiency of patients’ recovery, provide patients with real-time medical information, and relieve patients’ anxiety, thus reducing the need for repeated visits and improving patients’ postoperative quality of life.
- 10 June 2025
- Published by SAGE Publications in Journal of Telemedicine and Telecare
- Vol. 32 (2) , 151-162
Exploration of a remote swallowing training model after laryngeal cancer surgery: Non-randomized concurrent controlled trial
Background: Patients with supraglottic laryngeal carcinoma need to receive swallowing rehabilitation training. During the COVID-19 pandemic, patients do not have the conditions to visit the hospital for follow up frequently, so it is imperative to explore a new remote rehabilitation training model based on network conditions. Objective: To explore the effect of remote rehabilitation training mode on improving postoperative swallowing function in patients with supraglottic laryngeal carcinoma. Methods: Patients undergoing remote rehabilitation and video rehabilitation after surgical treatment for supraglottic laryngeal cancer, 16 each, were collected, and swallowing function at the start of transoral feeding was assessed as a baseline to compare swallowing function and the occurrence of complications at different stages of training. Results: Patients in the remote group began to show significant improvement in subjective swallowing function from the second week ( P < .001). In terms of objective swallowing function, although the remote group did not show a significant ( P = .66) advantage initially, it was also significantly better than the control group in the fourth week ( P <.001). These effects are even more impressive in patients undergoing open surgery ( P <.001). When completed the rehabilitation phase, patients in the remote group had a better nutritional status ( P = .03), especially postlaser surgery patients ( P = .02). Conclusions: The remote rehabilitation training model has an improving effect on patients with supraglottic laryngeal cancer postoperative swallowing disorder, which provides a theoretical basis for the design and improvement of the future remote rehabilitation training model. This study suggests that this training model should be incorporated into the daily postoperative management of patients with laryngeal cancer to improve the efficiency of patients’ recovery, provide patients with real-time medical information, and relieve patients’ anxiety, thus reducing the need for repeated visits and improving patients’ postoperative quality of life.
- Open Access
- 28 April 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-11
Gene mutations and differentiation in laryngeal and pharyngeal squamous cell carcinoma
Objective To explore the characteristics of genomic variation patterns in Chinese patients with laryngeal and pharyngeal squamous cell carcinoma (SCC) and their correlation with differentiation and clinical significance. Methods We analyzed genomic variations in 45 patients. Mutation patterns were evaluated using the 688 panel. We evaluated the correlation among degree of differentiation, patient prognosis, and mutation status and also analyzed 564 HNSCC samples from the UALCAN database. Results Significant differences were observed in overall survival (OS) and progression-free survival (PFS) among patients with different degrees of differentiation. Based on the DriverML model, we found that the genes with the highest mutation rates were neurogenic locus notch homolog protein 1 (NOTCH1), tumor protein 53 (TP53), FAT atypical cadherin 1 (FAT1), and mitogen-activated protein kinase kinase kinase 4 (MAP3 K4) (over 30%). We are the first to our knowledge to propose that MAP3 K4 (33%) may be a driving gene for Chinese SCC patients. Moreover, NOTCH1 and CUB and sushi multiple domains 3 (CSMD3) were mutually exclusive (p < 0.05). CSMD3 mutations were primarily found in poorly differentiated patients (83%, 5/6). Furthermore, NOTCH1wild and MAP3 K4wild were mainly present in poorly differentiated patients (p = 0.011) as well. We also validated the differential expression of NOTCH1 and MAP3 K4 and their association (p < 0.05) with tumor differentiation using 564 HNSCC samples from the UALCAN database. Conclusion We identified a potential new driving gene, MAP3 K4, in Chinese SCC patients and confirmed that the interaction between NOTCH1-MAP3 K4 may affect the differentiation of laryngeal and pharyngeal SCC. However, further exploration and large-scale sample validation are needed.
- 28 April 2025
- Published by Springer Nature in Discover Oncology
- Vol. 16 (1) , 1-11
Open AccessGene mutations and differentiation in laryngeal and pharyngeal squamous cell carcinoma
Objective To explore the characteristics of genomic variation patterns in Chinese patients with laryngeal and pharyngeal squamous cell carcinoma (SCC) and their correlation with differentiation and clinical significance. Methods We analyzed genomic variations in 45 patients. Mutation patterns were evaluated using the 688 panel. We evaluated the correlation among degree of differentiation, patient prognosis, and mutation status and also analyzed 564 HNSCC samples from the UALCAN database. Results Significant differences were observed in overall survival (OS) and progression-free survival (PFS) among patients with different degrees of differentiation. Based on the DriverML model, we found that the genes with the highest mutation rates were neurogenic locus notch homolog protein 1 (NOTCH1), tumor protein 53 (TP53), FAT atypical cadherin 1 (FAT1), and mitogen-activated protein kinase kinase kinase 4 (MAP3 K4) (over 30%). We are the first to our knowledge to propose that MAP3 K4 (33%) may be a driving gene for Chinese SCC patients. Moreover, NOTCH1 and CUB and sushi multiple domains 3 (CSMD3) were mutually exclusive (p < 0.05). CSMD3 mutations were primarily found in poorly differentiated patients (83%, 5/6). Furthermore, NOTCH1wild and MAP3 K4wild were mainly present in poorly differentiated patients (p = 0.011) as well. We also validated the differential expression of NOTCH1 and MAP3 K4 and their association (p < 0.05) with tumor differentiation using 564 HNSCC samples from the UALCAN database. Conclusion We identified a potential new driving gene, MAP3 K4, in Chinese SCC patients and confirmed that the interaction between NOTCH1-MAP3 K4 may affect the differentiation of laryngeal and pharyngeal SCC. However, further exploration and large-scale sample validation are needed.
- Open Access
- 25 February 2025
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 74 (4) , 1-7
Study on pathological factors affecting the sensitivity of neoadjuvant therapy in hypopharyngeal cancer
Objective Hypopharyngeal squamous cell carcinoma (HSCC) is a highly malignant tumor type in the head and neck region. In recent years, neoadjuvant therapy has significantly improved the laryngeal preservation rate among patients. However, there are variations in the efficacy of neoadjuvant therapy, and the identification of reliable predictive biomarkers for its efficacy remains a challenging research focus. This study aims to explore the correlation between the expression of P53, P16, and Ki67 and the response to neoadjuvant therapy. Methods A retrospective analysis was conducted on 120 patients who underwent neoadjuvant therapy at Beijing Tongren Hospital, Capital Medical University, from January 2021 to June 2024. Patients were grouped based on their treatment response and the type of neoadjuvant therapy received. Group analysis were employed to assess the predictive value of P53, P16, and Ki67 for treatment efficacy across different neoadjuvant therapy groups. Results A total of 120 patients were included in the study, with 60 patients each in the good response and poor response groups. The study comprised three neoadjuvant therapy groups: neoadjuvant chemotherapy, neoadjuvant targeted therapy combined with chemotherapy, and neoadjuvant immunotherapy combined with chemotherapy. Each group had 20 patients with good and poor responses, respectively. Among patients with P53 positivity, the effective rate after neoadjuvant therapy was 35.94%, significantly lower than the 66.07% observed in P53negative patients (p = 0.0017). For P16 positivity, the effective rate was 28.57%, lower than the 52.83% in P16negative patients (p = 0.0880). For patients with Ki67 < 60%, the effective rate was 33.33%, significantly lower than the 66.67% in those with Ki67 ≥ 60% (p = 0.0005). Comprehensively evaluate confirmed that P53 positivity and Ki67 < 60% were associated with poor response to neoadjuvant therapy, while P53 negativity and Ki67 ≥ 60% were associated with good response. Conclusion Our findings suggest that the combination of P53 and P16 can be used as a preliminary tool to assess the efficacy of neoadjuvant therapy in patients with HSCC. Specifically, patients with P53 positivity and Ki67 < 60% tend to have lower sensitivity to neoadjuvant therapy. Further research may be needed to clarify the precise role of P16 in HSCC.
- 25 February 2025
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 74 (4) , 1-7
Open AccessStudy on pathological factors affecting the sensitivity of neoadjuvant therapy in hypopharyngeal cancer
Objective Hypopharyngeal squamous cell carcinoma (HSCC) is a highly malignant tumor type in the head and neck region. In recent years, neoadjuvant therapy has significantly improved the laryngeal preservation rate among patients. However, there are variations in the efficacy of neoadjuvant therapy, and the identification of reliable predictive biomarkers for its efficacy remains a challenging research focus. This study aims to explore the correlation between the expression of P53, P16, and Ki67 and the response to neoadjuvant therapy. Methods A retrospective analysis was conducted on 120 patients who underwent neoadjuvant therapy at Beijing Tongren Hospital, Capital Medical University, from January 2021 to June 2024. Patients were grouped based on their treatment response and the type of neoadjuvant therapy received. Group analysis were employed to assess the predictive value of P53, P16, and Ki67 for treatment efficacy across different neoadjuvant therapy groups. Results A total of 120 patients were included in the study, with 60 patients each in the good response and poor response groups. The study comprised three neoadjuvant therapy groups: neoadjuvant chemotherapy, neoadjuvant targeted therapy combined with chemotherapy, and neoadjuvant immunotherapy combined with chemotherapy. Each group had 20 patients with good and poor responses, respectively. Among patients with P53 positivity, the effective rate after neoadjuvant therapy was 35.94%, significantly lower than the 66.07% observed in P53negative patients (p = 0.0017). For P16 positivity, the effective rate was 28.57%, lower than the 52.83% in P16negative patients (p = 0.0880). For patients with Ki67 < 60%, the effective rate was 33.33%, significantly lower than the 66.67% in those with Ki67 ≥ 60% (p = 0.0005). Comprehensively evaluate confirmed that P53 positivity and Ki67 < 60% were associated with poor response to neoadjuvant therapy, while P53 negativity and Ki67 ≥ 60% were associated with good response. Conclusion Our findings suggest that the combination of P53 and P16 can be used as a preliminary tool to assess the efficacy of neoadjuvant therapy in patients with HSCC. Specifically, patients with P53 positivity and Ki67 < 60% tend to have lower sensitivity to neoadjuvant therapy. Further research may be needed to clarify the precise role of P16 in HSCC.
- Open Access
- 1 January 2025
- Published by SAGE Publications in Science Progress
- Vol. 108 (1)
Exploration of the role of AIM2/IL-1β in adult laryngeal papilloma
Objectives: Human papillomavirus (HPV) infection is closely related to upper respiratory mucosal lesions, and the most common disease is adult upper respiratory papilloma, which has a certain probability of cancer transformation.This study conducted in vitro tissue and cell experiments to explore the inflammatory mechanisms associated with HPV + adult laryngeal papilloma. Methods: We compared differential expression of AIM2 and IL-1β between HPV (High-risk) negative and positive adult laryngeal papilloma patients. In vitro experiments were conducted to investigate the differences in expression of AIM2, Caspase-1, and IL-1β in HPV− and HPV+ upper respiratory mucosal cells. Results: The expression level of AIM2 and IL-1β was higher in HPV (High-risk) positive papilloma tissue than HPV (High-risk) negative papilloma tissue. The expression of AIM2, Caspase-1, and IL-1β in HPV+ cells was also significantly higher than in HPV− cells. Conclusions: The expression of IL-1β mediated by AIM2 was associated with chronic inflammation of upper respiratory mucosal tissue caused by HPV infection, and it may yet be associated with further pathological changes.
- 1 January 2025
- Published by SAGE Publications in Science Progress
- Vol. 108 (1)
Open AccessExploration of the role of AIM2/IL-1β in adult laryngeal papilloma
Objectives: Human papillomavirus (HPV) infection is closely related to upper respiratory mucosal lesions, and the most common disease is adult upper respiratory papilloma, which has a certain probability of cancer transformation.This study conducted in vitro tissue and cell experiments to explore the inflammatory mechanisms associated with HPV + adult laryngeal papilloma. Methods: We compared differential expression of AIM2 and IL-1β between HPV (High-risk) negative and positive adult laryngeal papilloma patients. In vitro experiments were conducted to investigate the differences in expression of AIM2, Caspase-1, and IL-1β in HPV− and HPV+ upper respiratory mucosal cells. Results: The expression level of AIM2 and IL-1β was higher in HPV (High-risk) positive papilloma tissue than HPV (High-risk) negative papilloma tissue. The expression of AIM2, Caspase-1, and IL-1β in HPV+ cells was also significantly higher than in HPV− cells. Conclusions: The expression of IL-1β mediated by AIM2 was associated with chronic inflammation of upper respiratory mucosal tissue caused by HPV infection, and it may yet be associated with further pathological changes.
- 3 December 2024
- Published by Elsevier in Cellular Signalling
- Vol. 127, 111545
AIM2 promotes the progression of HNSCC via STAT1 mediated transcription and IL-17/MAPK signaling
- 3 December 2024
- Published by Elsevier in Cellular Signalling
- Vol. 127, 111545
AIM2 promotes the progression of HNSCC via STAT1 mediated transcription and IL-17/MAPK signaling
- Open Access
- 17 October 2024
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 24 (6) , 1776-1784
Analysis of Th1/Th2 cytokine profile and clinical characteristics of patients with head and neck squamous cell carcinoma
Immune system biomarkers in cancer pathogenesis offer new therapeutic avenues, as seen in cytokine (CK) profiles of laryngeal and hypopharyngeal tumors. A retrospective analysis was conducted on 58 patients with laryngeal and hypopharyngeal tumors and 27 patients with benign vocal cord lesions to explore the role of serum CKs in these diseases’ characteristics and immunotherapy. The differences in the levels of 12 cytokines were measured. Additionally, the study examined the correlation between T helper cells (Th)1/Th2 cytokine levels and the clinical characteristics and immunotherapy efficacy of laryngeal and hypopharyngeal cancers. The results show that the balance of Th1/Th2 is biased towards Th2 in patients with laryngeal and hypopharyngeal tumors. Among these, interleukin (IL)-6 (P = 0.021) was highly expressed in laryngeal tumors, and the expression levels of IL-1β (P = 0.008), IL-6 (P = 0.005), and IL-8 (P = 0.05) were higher in patients with poorly differentiated laryngeal tumors. The level of IL-4 (P = 0.0048) was significantly correlated with tumor location. The expression levels of IL-2 (P = 0.010), IL-4 (P = 0.028), IL-10 (P = 0.011), IL-12p70 (P = 0.034), IL-17 (P = 0.024), tumor necrosis factor (TNF)-α (P = 0.003), and interferon (IFN)-γ (P = 0.007) were related to lymph node metastasis. The level of IFN-γ (P = 0.016) was correlated with the efficacy of neoadjuvant therapy, while the level of IFN-α (P = 0.013) was significantly correlated with programmed death ligand 1 (PD-L1) expression. The Principal Component Analysis (PCA) results showed that patients with tumors, poor differentiation, and lymph node metastasis had higher levels of Th1 and Th2 cytokine separation. In conclusion, the shift in the balance of Th1 and Th2 cytokine expression indicates higher tumor invasiveness, and IFN has potential as a circulating molecular marker for immunotherapy of head and neck squamous cell carcinoma.
- 17 October 2024
- Published by Association of Basic Medical Sciences of FBIH in Biomolecules and Biomedicine
- Vol. 24 (6) , 1776-1784
Open AccessAnalysis of Th1/Th2 cytokine profile and clinical characteristics of patients with head and neck squamous cell carcinoma
Immune system biomarkers in cancer pathogenesis offer new therapeutic avenues, as seen in cytokine (CK) profiles of laryngeal and hypopharyngeal tumors. A retrospective analysis was conducted on 58 patients with laryngeal and hypopharyngeal tumors and 27 patients with benign vocal cord lesions to explore the role of serum CKs in these diseases’ characteristics and immunotherapy. The differences in the levels of 12 cytokines were measured. Additionally, the study examined the correlation between T helper cells (Th)1/Th2 cytokine levels and the clinical characteristics and immunotherapy efficacy of laryngeal and hypopharyngeal cancers. The results show that the balance of Th1/Th2 is biased towards Th2 in patients with laryngeal and hypopharyngeal tumors. Among these, interleukin (IL)-6 (P = 0.021) was highly expressed in laryngeal tumors, and the expression levels of IL-1β (P = 0.008), IL-6 (P = 0.005), and IL-8 (P = 0.05) were higher in patients with poorly differentiated laryngeal tumors. The level of IL-4 (P = 0.0048) was significantly correlated with tumor location. The expression levels of IL-2 (P = 0.010), IL-4 (P = 0.028), IL-10 (P = 0.011), IL-12p70 (P = 0.034), IL-17 (P = 0.024), tumor necrosis factor (TNF)-α (P = 0.003), and interferon (IFN)-γ (P = 0.007) were related to lymph node metastasis. The level of IFN-γ (P = 0.016) was correlated with the efficacy of neoadjuvant therapy, while the level of IFN-α (P = 0.013) was significantly correlated with programmed death ligand 1 (PD-L1) expression. The Principal Component Analysis (PCA) results showed that patients with tumors, poor differentiation, and lymph node metastasis had higher levels of Th1 and Th2 cytokine separation. In conclusion, the shift in the balance of Th1 and Th2 cytokine expression indicates higher tumor invasiveness, and IFN has potential as a circulating molecular marker for immunotherapy of head and neck squamous cell carcinoma.
- Open Access
- 11 September 2024
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 91 (1) , 101484
Analysis of the role of IL-1 family and related genes in head and neck squamous cell carcinoma
- 11 September 2024
- Published by Elsevier in Brazilian Journal of Otorhinolaryngology
- Vol. 91 (1) , 101484
Open AccessAnalysis of the role of IL-1 family and related genes in head and neck squamous cell carcinoma
- RetractedOpen Access
- 12 March 2024
- Published by Wiley in International Wound Journal
- Vol. 21 (3) , e14751
RETRACTED: Impact of stapler versus manual closure techniques on pharyngocutaneous fistula development post‐total laryngectomy: A systematic review and meta‐analysis
Pharyngocutaneous fistula (PCF) is a major complication after total laryngectomy, with significant morbidity and mortality. Whether mechanical stapler closure of the pharynx reduces fistula rates compared to hand‐sewn techniques remains unclear. We conducted an updated systematic review and meta‐analysis to clarify this question. Five databases were systematically searched from inception through November 2023 for studies comparing stapler versus suture closure for fistula outcomes after laryngectomy. Odds ratios (OR) were pooled using random‐effects models and fixed‐effects models. Subgroup and sensitivity analyses were performed. Risk of bias was appraised using NHLBI tools. Nine studies with 803 patients were included. Mechanical closure significantly reduced fistula incidence versus suture closure (OR = 0.57, 95% CI 0.34–0.95, p = 0.03). Subgroup analysis found that stapling's protective effect varied by patient age, country/region, linear stapler size and female percentage. Stapling reduced fistula odds by 80% in the Turkey subgroup (OR = 0.20, 95% CI 0.09–0.50) but showed no benefit in other regions. Patients <60 years showed an 84% fistula reduction with stapling (OR = 0.17, 95% CI 0.06–0.45), whereas older subgroups did not. Linear stapler size of 60 mm significantly reduced fistula occurrence while 75 mm did not. There was no evidence that low female percentage mitigated stapling benefits. Mechanical stapler closure after total laryngectomy meaningfully reduces the likelihood of postoperative PCF formation compared to hand‐sewn closure, especially for patients younger than 60 years old. The absolute risk reduction supports its utility to prevent this complication.
- 12 March 2024
- Published by Wiley in International Wound Journal
- Vol. 21 (3) , e14751
RetractedOpen AccessRETRACTED: Impact of stapler versus manual closure techniques on pharyngocutaneous fistula development post‐total laryngectomy: A systematic review and meta‐analysis
Pharyngocutaneous fistula (PCF) is a major complication after total laryngectomy, with significant morbidity and mortality. Whether mechanical stapler closure of the pharynx reduces fistula rates compared to hand‐sewn techniques remains unclear. We conducted an updated systematic review and meta‐analysis to clarify this question. Five databases were systematically searched from inception through November 2023 for studies comparing stapler versus suture closure for fistula outcomes after laryngectomy. Odds ratios (OR) were pooled using random‐effects models and fixed‐effects models. Subgroup and sensitivity analyses were performed. Risk of bias was appraised using NHLBI tools. Nine studies with 803 patients were included. Mechanical closure significantly reduced fistula incidence versus suture closure (OR = 0.57, 95% CI 0.34–0.95, p = 0.03). Subgroup analysis found that stapling's protective effect varied by patient age, country/region, linear stapler size and female percentage. Stapling reduced fistula odds by 80% in the Turkey subgroup (OR = 0.20, 95% CI 0.09–0.50) but showed no benefit in other regions. Patients <60 years showed an 84% fistula reduction with stapling (OR = 0.17, 95% CI 0.06–0.45), whereas older subgroups did not. Linear stapler size of 60 mm significantly reduced fistula occurrence while 75 mm did not. There was no evidence that low female percentage mitigated stapling benefits. Mechanical stapler closure after total laryngectomy meaningfully reduces the likelihood of postoperative PCF formation compared to hand‐sewn closure, especially for patients younger than 60 years old. The absolute risk reduction supports its utility to prevent this complication.
- Open Access
- 4 December 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Identification and validation of a T cell marker gene-based signature to predict prognosis and immunotherapy response in gastric cancer
Although the role of T cells in tumor immunity and modulation of the tumor microenvironment (TME) has been extensively studied, their precise involvement in gastric adenocarcinoma remains inadequately explored. In this work, we analyzed the single-cell RNA sequencing data set in GSE183904 and identified 322 T cell marker genes using the “FindAllMarkers” method of the R package “Seurat”. STAD patients in the TCGA database were divided into high-risk and low-risk categories based on risk scores. The five-gene prediction signature based on T cell marker genes can predict the prognosis of gastric cancer patients with high accuracy. In the training cohort, the areas under the receiver operating characteristic (ROC) curve were 0.667, 0.73, and 0.818 at 1, 3, and 5 years. External validation of the predictive signature was also performed using multiple clinical subgroups and GEO cohorts. To help with practical application, a diagnostic model was created that shows values of 0.732, 0.752, and 0.816 for the relevant areas under the ROC curve at 1, 3, and 5 years. The T cell marker genes identified in this study may serve as potential therapeutic targets, and the developed predictive signatures and nomograms may aid in the clinical management of gastric cancer.
- 4 December 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-12
Open AccessIdentification and validation of a T cell marker gene-based signature to predict prognosis and immunotherapy response in gastric cancer
Although the role of T cells in tumor immunity and modulation of the tumor microenvironment (TME) has been extensively studied, their precise involvement in gastric adenocarcinoma remains inadequately explored. In this work, we analyzed the single-cell RNA sequencing data set in GSE183904 and identified 322 T cell marker genes using the “FindAllMarkers” method of the R package “Seurat”. STAD patients in the TCGA database were divided into high-risk and low-risk categories based on risk scores. The five-gene prediction signature based on T cell marker genes can predict the prognosis of gastric cancer patients with high accuracy. In the training cohort, the areas under the receiver operating characteristic (ROC) curve were 0.667, 0.73, and 0.818 at 1, 3, and 5 years. External validation of the predictive signature was also performed using multiple clinical subgroups and GEO cohorts. To help with practical application, a diagnostic model was created that shows values of 0.732, 0.752, and 0.816 for the relevant areas under the ROC curve at 1, 3, and 5 years. The T cell marker genes identified in this study may serve as potential therapeutic targets, and the developed predictive signatures and nomograms may aid in the clinical management of gastric cancer.